Clinical Trials Browser

Phase 4 × INDUSTRY × Lymphoproliferative Disorders × Clear all

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

NCT01990534 2021-04-09

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

AOC-MM

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma